Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML)
Clinical trial NCT04547062 · COMPLETED
Trial details
- NCT number
- NCT04547062
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2023-04-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.